Results 101 to 110 of about 34,117 (261)
Identification of Biosynthetic Inhibitors of Virulence Factor Entry Into Mammalian Cells [PDF]
Clostridioides difficile toxin B (TcdB) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the primary virulence factors behind the C.
Icho, Simoun
core +1 more source
Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network [PDF]
Antibiotic exposure can lead to unintended outcomes, including drug-drug interactions, adverse drug events, and healthcare-associated infections like Clostridioides difficile infection (CDI). Improving antibiotic use is critical to reduce an individual's
Bobashev, G.+13 more
core +2 more sources
Immune checkpoint inhibitor‐associated collagenous colitis exhibits distinct histopathological and immunophenotypic features compared to idiopathic cases, including prominent sub‐epithelial macrophage accumulation and neutrophilic cryptitis. These findings underscore the pathogenic impact of PD1/PD‐L1 axis blockade on colonic mucosa and expand the ...
Mohamed‐Amine Bani+10 more
wiley +1 more source
Management of Clostridioides difficile Infection [PDF]
Clostridioides (formerly Clostridium) difficile infection is among the most identified causes of health care-associated infections in US hospitals and remains a major public health problem. The incidence and severity of C difficile infection are high among critically ill patients.
Stephanie Quist+4 more
openaire +3 more sources
Background Clostridioides difficile infections (CDI) present significant health risks and are among the most important nosocomial infections. Ribotype (RT) 027 poses a particular risk due to its proposed “hypervirulence”. Traditionally, C.
Esther E. Dirks+9 more
doaj +1 more source
There has been a significant increase in hospital and community acquired Clostridioides difficile infection in the past decade. In addition to CDI, the rate of infection with enterohemorrhagic Escherichia coli (EHEC) has also increased by 28% in United ...
Farah Deshmukh+2 more
doaj +1 more source
Abstract Aims Previous studies have shown the COVID‐19 pandemic was associated with reductions in volume across a spectrum of non‐SARS‐CoV‐2 hospitalizations. In the present study, we examine the impact of the pandemic on patient safety and quality of care. Design This is a retrospective population‐based study of discharge abstracts. Methods We applied
Steven Habbous+4 more
wiley +1 more source
The effects of antibiotics on the gut microbiota can lead to enhanced colonization of Clostridioides difficile (C. difficile) and toxin-mediated pathogenesis.
Joshua R. Fletcher+7 more
doaj +1 more source
Pharmacologic Management of Non‐Traumatic Dental Conditions in US Emergency Departments, 2018–2022
ABSTRACT Objective This study examines opioid and antibiotic prescribing by United States emergency departments (EDs) for non‐traumatic dental conditions (NTDCs) between 2018 and 2022. Methods This is a secondary analysis of nationally representative ED visits using the National Hospital Ambulatory Medical Care Survey (NHAMCS) with an NTDC as the ...
Leah I. Leinbach+3 more
wiley +1 more source
ABSTRACT Rifampin is an enigma among antimicrobials. Blood and tissue compartment concentrations are a “moving target” along the treatment course due to the complex pharmacodynamic interactions within the body. Rifampin concomitant therapies are for the prevention and treatment of Rhodococcus equi infection in foals, for nearly 40 years.
Keith Edward Baptiste+4 more
wiley +1 more source